Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/13/2003WO2003020751A2 Homing peptides
03/13/2003WO2003020746A1 Modified transferrin fusion proteins
03/13/2003WO2003020743A1 Methods of expressing transgenes
03/13/2003WO2003020742A1 Assay for detection of human parvovirus b19 nucleic acid
03/13/2003WO2003020741A1 Nucleic acid compositions conferring altered visual phenotypes
03/13/2003WO2003020739A2 Novel lna compositions and uses thereof
03/13/2003WO2003020734A2 Labeled nucleoside polyphosphates
03/13/2003WO2003020702A2 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003WO2003020415A2 Treatment of substrates using an electrochemical method
03/13/2003WO2003020322A1 Vector used to induce an immune response
03/13/2003WO2003020308A1 Chicken anemia virus vaccine from cell line
03/13/2003WO2003020220A2 Mitochondrial biology expression arrays
03/13/2003WO2003020040A1 Oral vaccines
03/13/2003WO2003020025A2 Nucleic acid compositions conferring insect control in plants
03/13/2003WO2003020017A1 Identification and expression of heterologous nucleic acid sequences encoding heterologous fatty acid modifying enzymes in plants
03/13/2003WO2003020016A2 SEED SPECIFIC 7S α PROMOTER FOR EXPRESSING GENES IN PLANTS
03/13/2003WO2003020015A2 Methods to produce transgenic plants resistant to osmotic stress
03/13/2003WO2003020013A1 Plant-derived resistance gene
03/13/2003WO2003020005A2 Lp mammalian proteins; related reagents
03/13/2003WO2003002741A3 Nucleic acids encoding nuclear receptors
03/13/2003WO2003000847A3 Membrane associated progesterone receptor
03/13/2003WO2003000174A3 Compositions and methods for intracellular delivery
03/13/2003WO2002099038A3 Adsls as modifiers of the p53 pathway and methods of use
03/13/2003WO2002097050A3 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions
03/13/2003WO2002095055A8 Compositions and methods for use in isolation of nucleic acid molecules
03/13/2003WO2002095006A3 Muscle-specific expression vectors
03/13/2003WO2002092757A3 Enzyme over-producing transgenic microorganisms
03/13/2003WO2002086095A3 Transcription factor network discovery methods
03/13/2003WO2002085932A3 Constructs and methods for expression of recombinant hcv envelope proteins
03/13/2003WO2002083896A3 Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
03/13/2003WO2002083840A3 Compositions and methods for transepithelial transport of membrane-bounded vesicles and virions
03/13/2003WO2002081514A3 A novel f-box protein
03/13/2003WO2002079445A3 Transgenic mice containing kallikrein-like gene disruptions
03/13/2003WO2002079431A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/13/2003WO2002079237A3 Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
03/13/2003WO2002078715A8 Method for induction of an antigen specific anti-inflammatory response
03/13/2003WO2002077217A3 Human dual specificity protein phosphatase 7-like protein
03/13/2003WO2002077213A3 New elongase gene and production of δ9-polyunsaturated fatty acids
03/13/2003WO2002077158A3 Root specific, stimulant inducible promoter and its use
03/13/2003WO2002075275A3 Polyclonal populations of bispecific molecules and methods of production and uses thereof
03/13/2003WO2002074979A3 Expression profiles and methods of use
03/13/2003WO2002074942A3 Campylobacter glycosyltransferases for biosynthesis of gangliosides and ganglioside mimics
03/13/2003WO2002074935A3 Use of telomerase reverse transcriptase to create homozygous knockout animals
03/13/2003WO2002074909A3 Cell cycle nucleic acids, polypeptides and uses thereof
03/13/2003WO2002072890A8 Improved in vitro synthesis system
03/13/2003WO2002072782A3 Master activators of pathogen responsive genes
03/13/2003WO2002072634A3 Recombinant proteinase k
03/13/2003WO2002070713A3 Dna sequence from kluyveromyces marxianus comprising regulatory regions for expressing proteins
03/13/2003WO2002070702A3 Polypeptides capable of interacting with smad polypeptide
03/13/2003WO2002070693A3 Novel abca6 transporter and uses thereof
03/13/2003WO2002068654A3 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus
03/13/2003WO2002068629A3 Dna constructs for cytoplasmic and mithochondrial expression and methods of making and using same
03/13/2003WO2002064803A3 Identification of seeds or plants using phenotyic markers
03/13/2003WO2002064629A3 Isolated human transporter proteins, nucleic acid molecules encoding them and uses thereof
03/13/2003WO2002063012A3 Ragweed allergens
03/13/2003WO2002062832A3 Modified human brain-derived neutrophic factor (bdnf) with reduced immunogenicity
03/13/2003WO2002061106A3 Method for producing cysteine, cystine and glutathione by fermentation
03/13/2003WO2002061084A3 Nt69, a nucleoside transporter family member and uses therefor
03/13/2003WO2002061043A3 Fungal resistant transgenic plants
03/13/2003WO2002061038A3 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
03/13/2003WO2002059309A3 Anthozoa derived chromoproteins, fluorescent mutants thereof and methods for using the same
03/13/2003WO2002056668A3 Methods to control the host range of retroviral vectors
03/13/2003WO2002055104A3 Acne vaccine
03/13/2003WO2002053754A3 Human protease and polynucleotides encoding the same
03/13/2003WO2002053726A3 Protein-protein interactions in adipocyte cells
03/13/2003WO2002050286A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/13/2003WO2002048363A3 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof
03/13/2003WO2002047717A3 Targeted enzyme prodrug therapy
03/13/2003WO2002046461A3 Method for identifying modulators of transcription
03/13/2003WO2002046412A3 Regulation of angiogenesis with zinc finger proteins
03/13/2003WO2002046410A3 Prostate-specific polypeptide pamp and encoding nucleic acid molecules
03/13/2003WO2002046407A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002046369A3 Yeast-based assays involving gpcrs
03/13/2003WO2002044409A3 Substrate linked directed evolution (slide)
03/13/2003WO2002044399A3 In vitro transcription method for rna amplification
03/13/2003WO2002044381A3 Human vno receptor (r1)
03/13/2003WO2002044380A3 Master bone formation transcription factor: compositions and methods of use
03/13/2003WO2002044379A3 Transforming growth factor-beta-related molecules and uses thereof
03/13/2003WO2002044364A3 Polypeptides involved in immune response
03/13/2003WO2002044350A3 Cyclodextrin glucanotransferase (cgtase), obtained from bacillus agaradherens (dsm 9948) and detergents and cleaning agents containing said novel cyclodextrin glucanotransferase
03/13/2003WO2002042471A3 Methods and materials for the synthesis of organic products
03/13/2003WO2002042466A3 Nucleotide sequences coding for the cysq gene
03/13/2003WO2002042456A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/13/2003WO2002042454A3 Gene involved in schizophrenia
03/13/2003WO2002042332A3 Truncated cd200
03/13/2003WO2002040697A3 Metabolic rate shifts in fermentations expressing recombinant proteins
03/13/2003WO2002040680A3 Death domain proteins
03/13/2003WO2002040660A3 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae
03/13/2003WO2002038608A3 Methods of screening for ltrpc2 modulators
03/13/2003WO2002036829A3 Methods of diagnosing, preventing and treating neurological disorders and neuronal injuries
03/13/2003WO2002036773A3 Nod2 nucleic acids and proteins
03/13/2003WO2002036755A3 Regulation of human inositolpolyphosphate 5-phosphatase
03/13/2003WO2002036613A3 Regulation of human patched-like protein
03/13/2003WO2002034916A3 Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor
03/13/2003WO2002034762A3 Method for generating a library of oligonucleotides comprising a controlled distribution of mutations
03/13/2003WO2002034288A3 Vaccine for treating allergy
03/13/2003WO2002031511A3 Modulation of ligand binding/enzymatic activity of alpha beta proteins
03/13/2003WO2002031186A3 Method for the detection of cytosine methylations
03/13/2003WO2002031177A3 Method for synthesising peptides, peptide mimetics and proteins
03/13/2003WO2002031132A3 8843, a human dual specificity phosphatase family member and uses therefor
1 ... 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 ... 4023